We have the joy to announce that Dr. Jussi Kosola has started the SVF knee osteoarthritis study in Finland.
Q-graft is he only system for harvesting regenerative cells (SVF) that can be used at the point-of-care.
The new compact Q-graft® system for the intraoperative separation and collection of regenerative cells (stromal vascular fraction/ SVF) from adipose tissue will support and enhance the research and clinical application of SVF cells for many therapeutic indications.
Unlike other methods, the Q-graft® system stays on the sterile instrument table in the OR throughout the treatment and thus at the point-of-care.
Related articles
Mediq expands in Nordics with UpViser Oy acquisition
Mediq has acquire...

UpViser and Human Med AG have been partners since 2008. The success story o...

We are incredibly proud and happy to receive this recognized award once aga...
Read more:
Simunec 2020 - Treatment of Grade 3 and 4 Osteoarthritis...